Long-acting growth hormone treatment
US12016903B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Nov 20, 2015 |
| Grant date | Jun 25, 2024 |
| Priority date | — |
| Expiry date | Nov 20, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P5/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates a pharmaceutical formulation comprising a long-acting growth hormone for use in a method of treating growth hormone deficiency, wherein the long-acting growth hormone formulation is administered to a patient in a bracketed dosage regimen, to a multitude of unit dosage forms comprising a long-acting growth hormone formulation, wherein the unit dosage forms comprise increasing amounts of growth hormone equivalents and wherein the amount of growth hormone equivalents increases by at least 10% between one unit dosage form and the next higher dosage form; their use in a method of treating growth hormone deficiency and method of treating growth hormone deficiency in a bracketed dosing regimen.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.